Miniature organs grown in the lab can organize themselves into complex shapes, which enables scientists to use them to study disease. The trouble is they never do it the same way twice, which has made ...

Horses provide a strong translational model for human osteoarthritis -- Clinical investigation authorized by Belgian regulatory authority -- Allegro's hydrogel is first-in-class potentially ...

Biovance, Biovance 3L, Natalin, Acelagraft, Interfyl and Centaflex licensed to NEXGEL are established commercial products widely used today in ...

Consideration for portfolio will consist of a $15 million upfront cash payment and potentially an additional $20 million in milestone payments based on net sales targets related to the portfolio Trans ...

Biomedical engineer advances sustainable wound care by converting chicken feather waste into biocompatible hydrogel ...

Fziomed, Inc. ("Fziomed" or the "Company"), a recognized global leader in postsurgical adhesion prevention with the best-in-class synthetic, absorbable gel technology platform, today announced results ...

Biomaterials are taking medicine by storm – explore some recent preclinical advances in the field that may yield therapeutic benefits.

NEXGEL, Inc. (NASDAQ:NXGL) has signed an asset purchase and exclusive licensing agreement with Celularity, Inc. to obtain rights to Celularity’s commercial-stage regenerative biomaterials portfolio, ...

Transaction expected to approximately triple NEXGEL's annual revenue to about $35 million and is expected to make the Company immediately profitable upon closing Licensing and acquiring a diversified ...

Transaction expected to approximately triple NEXGEL’s annual revenue to about $35 million and is expected to make the Company immediately profitable upon closing ...